PHARMACEUTICAL COMPOSITION COMPRISING SERUM AMYLOID P COMPONENT FOR PROPHYLACTIC OR THERAPEUTIC TREATMENT OF VIRUS INFECTIONS AND A KIT FOR DETECTING BINDING OF COMPOSITIONS TO VIRUS COMPONENTS

Pharmaceutical compositions comprising a protein serum amyloid P component (SAP) capable of binding viruses, especially myxovirus, e.g. influenza viruses and thereby preventing the transmission an d infection with such viruses. Preferred is mucosal administration, e.g. SAP incorporated in a nose spr...

Full description

Saved in:
Bibliographic Details
Main Authors NIELSEN, ELLEN HOLM, ANDERSEN, OVE, SVEHAG, SVEN-ERIK
Format Patent
LanguageEnglish
French
Published 02.06.2009
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Pharmaceutical compositions comprising a protein serum amyloid P component (SAP) capable of binding viruses, especially myxovirus, e.g. influenza viruses and thereby preventing the transmission an d infection with such viruses. Preferred is mucosal administration, e.g. SAP incorporated in a nose spray or nose drops. Also provided is a method for measuring the binding of SAP to the hemagglutinin of the prevailing influenza virus subtype and strain.</ SDOAB>
Bibliography:Application Number: CA19972247388